1991
DOI: 10.1097/00007890-199110000-00035
|View full text |Cite
|
Sign up to set email alerts
|

The Pathophysiologic Role of Endothelin in Acute Vascular Rejection After Renal Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
17
0

Year Published

1996
1996
2000
2000

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 39 publications
(18 citation statements)
references
References 0 publications
1
17
0
Order By: Relevance
“…Intravenous infusion of a selective ET-A receptor antagonist (BQ-123) on the day after ischemia improved GFR and preserved tubular function for sodium reabsorption, potassium excretion, and prevented fatal hyperkalemia [56], Similar protective effects of BQ-123 were observed in another rat study in which the antagonist was infused intravenously before renal artery occlusion and during reperfusion [57], On the other hand, a rat study showed that the number or affinity of glomerular ET receptors was not altered during initia tion and maintenance of ARF produced by 60 min renal artery occlusion, raising doubt that enhanced ET activity in glomeruli is responsible for the reduction in GFR in this model [58], There are scarce data in human studies to implicate and define the role of ET in the initiation or maintenance of ARF since only plasma levels have been examined and show conflicting results. In patients with ARF, plasma immunoreactive ET levels were reported to be elevated [59], In patients with renal transplantation complicated by acute tubular necrosis, plasma immunoreactive ET concentrations were normal but were elevated when vas cular rejection occurred [60]. However, another report showed that postrenal transplant acute tubular necrosis was associated with increased plasma immunoreactive ET levels, which also correlated positively with serum cre atinine concentrations [61].…”
Section: Acute Renal Failurementioning
confidence: 99%
“…Intravenous infusion of a selective ET-A receptor antagonist (BQ-123) on the day after ischemia improved GFR and preserved tubular function for sodium reabsorption, potassium excretion, and prevented fatal hyperkalemia [56], Similar protective effects of BQ-123 were observed in another rat study in which the antagonist was infused intravenously before renal artery occlusion and during reperfusion [57], On the other hand, a rat study showed that the number or affinity of glomerular ET receptors was not altered during initia tion and maintenance of ARF produced by 60 min renal artery occlusion, raising doubt that enhanced ET activity in glomeruli is responsible for the reduction in GFR in this model [58], There are scarce data in human studies to implicate and define the role of ET in the initiation or maintenance of ARF since only plasma levels have been examined and show conflicting results. In patients with ARF, plasma immunoreactive ET levels were reported to be elevated [59], In patients with renal transplantation complicated by acute tubular necrosis, plasma immunoreactive ET concentrations were normal but were elevated when vas cular rejection occurred [60]. However, another report showed that postrenal transplant acute tubular necrosis was associated with increased plasma immunoreactive ET levels, which also correlated positively with serum cre atinine concentrations [61].…”
Section: Acute Renal Failurementioning
confidence: 99%
“…In a clinical study of renal transplantation, the serum ET-1 concentration decreased after the graft function improved [8]. But when acute rejection occurs, the increase in the ET-1 level accompanied a decline of graft function [17][18][19]. These results suggested that ET-1 works in conjunction with renal function and, especially in renal transplantation, ET-1 may be a marker for rejection of the transplanted kidney.…”
Section: Discussionmentioning
confidence: 99%
“…It was demonstrated that ET-1 elevates c-fos, c-jun and c-myc expression and extracellular matrix protein synthesis [16, 171. Many of the studies of the role of ET in kidneys have concentrated on ET-1, very few studies of ET-3 have been reported. Circumstantial evidence exists for the potential pathophysiological role of ETin several renal abnormalities such as ischemia-induced acute renal failure, cyclosporine A-(CyA) and FK506 nephrotoxicity, radiocontrast nephrotoxicity, hepatorenal syndrome, and polycystic kidney disease [7,13,24,29,32].…”
Section: Introductionmentioning
confidence: 99%
“…Raised ET-1 blood levels were detected during vascular rejection in association with reduced ET-1 immunostaining in the endothelium [33]. In cellular rejection, where endothelial cells are intact, no significant elevation of plasma ET-1 was observed [32]. However, blood levels do not reflect the true biological significance of ET well since these peptides are rapidly cleared and only very high concentrations are detected.…”
Section: Introductionmentioning
confidence: 99%